| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Laboratory of Biophysics-Cytometry*
and
Department of Environmental Epidemiology and
Biostatistics,
National Institute for Cancer
Research and Treatment, Candiolo, Genoa, and Departments of
Pathology
and
Gastroenterology,§
S. Giovanni
Vecchio Hospital, Turin, Italy
Recent studies indicate that p21ras proteins mediate their multiple
cell functions through interactions with multiple effectors and that
the number of new effectors is growing. We recently reported that
K-ras2 mutations in human colorectal adenomas were associated with
chromosome instability and proliferation changes. In the present
study, we extend these previous observations. Hereditary and
multiple (n
5) adenomas and adenomas with early
cancer were excluded. Dysplasia was moderate in 91 cases and high
in 25, and the median adenoma size was 1.5 cm. K-ras2
spectrum analysis was done by sequence-specific
oligonucleotide hybridization using nuclear suspensions provided by
analysis and sorting of multiparameter flow cytometry. In
particular, tissue inflammatory cells were separated for DNA
diploid tumors, whereas DNA aneuploid epithelial subclones were
analyzed separately. K-ras2 mutations and DNA aneuploidy were both
detected in 29 of 116 (25%) cases. DNA aneuploid index was in the
near-diploid region in the majority of cases. DNA aneuploidy was
strongly associated with G
C/T transversions. An association was also
found between low S-phase values and G
A transitions. These findings
were confirmed using multivariate logistic regression analysis to
account for the effects of size, dysplasia,
site, type, age, and sex. These data suggest
that specific K-ras2 mutations in a subgroup of human sporadic
colorectal adenomas play a role in chromosome instability and,
contrary to expectations, are associated with inhibition of
proliferation.
This article has been cited by other articles:
![]() |
H J N Andreyev, R Benamouzig, M Beranek, P Clarke, D Cunningham, A R Norman, W Giaretti, A F P M de Goeij, B J Iacopetta, E Jullian, et al. Mutant K-ras2 in serum Gut, June 1, 2003; 52(6): 915 - 916. [Full Text] |
||||
![]() |
V. Patel, C. Ieethanakul, and J.S. Gutkind New Approaches To the Understanding of the Molecular Basis of Oral Cancer Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(1): 55 - 63. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |